{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:23:40Z","timestamp":1793363020267,"version":"4.5.0"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer J"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Twenty-five years after the Revised European American Classification of Lymphoid Neoplasms classification was published, its principle of an integrative approach to disease definition based on several parameters still prevails and has been adopted and expanded in the following World Health Organization classifications of tumors of the hematopoietic organs. The latest World Health Organization classification revised in 2017 comprises more than 80 entities of mature lymphoid neoplasms (B-cell, T-cell, and Hodgkin lymphomas), which are defined according to their morphology, immunophenotype, genetic lesions and molecular profiles, clinical features, and cellular derivation. The classification also recognizes both incipient and indolent lymphoid neoplasms with a low potential of progression. In this review, we highlight some of the new data and recent modifications introduced in the 2017 classification.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000451","type":"journal-article","created":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T21:02:18Z","timestamp":1591909338000},"page":"176-185","source":"Crossref","is-referenced-by-count":139,"title":["Lymphoma Classification"],"prefix":"10.1097","volume":"26","author":[{"given":"Laurence","family":"de Leval","sequence":"first","affiliation":[{"name":"Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib2-20230924","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","year":"1994","journal-title":"Blood"},{"key":"bib4-20230924","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/path.1700470309","article-title":"Reticulosis and reticulosarcoma. a histological classification","volume":"47","year":"1938","journal-title":"J Path Bact"},{"key":"bib5-20230924","first-page":"381","article-title":"Malignant lymphoma: a clinico-pathologic survey of 618 cases","volume":"18","year":"1942","journal-title":"Am J Pathol"},{"key":"bib6-20230924","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJM194407132310201","article-title":"Hodgkin's disease II: pathology","volume":"231","year":"1944","journal-title":"N Engl J Med"},{"issue":"suppl","key":"bib8-20230924","first-page":"193","article-title":"The histopathology of malignant lymphoma","volume":"31","year":"1975","journal-title":"Br J Haematol"},{"key":"bib9-20230924","first-page":"292","article-title":"Updated Kiel classification for lymphomas [letter] [published correction appears in Lancet 1988;1(8581):372]","volume":"1","year":"1988","journal-title":"Lancet"},{"key":"bib10-20230924","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","year":"1974","journal-title":"Cancer"},{"key":"bib11-20230924","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"bib12-20230924","first-page":"1594","article-title":"Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"key":"bib13-20230924","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"bib14-20230924","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa associated lymphoid tissue. A distinctive B cell lymphoma","volume":"52","year":"1983","journal-title":"Cancer"},{"key":"bib15-20230924","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib16-20230924","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM198211113072002","article-title":"Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma","volume":"307","year":"1982","journal-title":"N Engl J Med"},{"key":"bib17-20230924","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","year":"1999","journal-title":"N Engl J Med"},{"key":"bib18-20230924","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1182\/blood.V84.5.1359.1359","article-title":"Classification of lymphoid neoplasms","volume":"84","year":"1994","journal-title":"Blood"},{"key":"bib19-20230924","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"bib20-20230924","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","year":"1998","journal-title":"J Clin Oncol"},{"key":"bib23-20230924","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2016.71.7603","article-title":"Clinical applications of the genomic landscape of aggressive non-hodgkin lymphoma","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"key":"bib24-20230924","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"bib25-20230924","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"bib26-20230924","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma","volume":"127","year":"2016","journal-title":"Blood"},{"key":"bib27-20230924","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","year":"2011","journal-title":"Nature genetics"},{"key":"bib29-20230924","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","year":"2016","journal-title":"Blood"},{"key":"bib30-20230924","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/HS9.0000000000000169","article-title":"The need for a consensus next-generation sequencing panel for mature lymphoid malignancies","volume":"3","year":"2019","journal-title":"Hemasphere"},{"key":"bib31-20230924","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2013.08.003","article-title":"Monoclonal B cell lymphocytosis and \u201cin situ\u201d lymphoma","volume":"24","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"bib32-20230924","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2011-05-355255","article-title":"Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma","volume":"118","year":"2011","journal-title":"Blood"},{"key":"bib33-20230924","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/leu.2013.307","article-title":"Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma","volume":"28","year":"2014","journal-title":"Leukemia"},{"key":"bib34-20230924","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3324\/haematol.2013.085506","article-title":"Follicular lymphoma\u2013like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies","volume":"98","year":"2013","journal-title":"Haematologica"},{"key":"bib35-20230924","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","article-title":"Early lesions of follicular lymphoma: a genetic perspective","volume":"99","year":"2014","journal-title":"Haematologica"},{"key":"bib36-20230924","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-017-2199-7","article-title":"The clinicopathologic spectrum of mature aggressive B cell lymphomas","volume":"471","year":"2017","journal-title":"Virchows Arch"},{"key":"bib37-20230924","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","year":"2004","journal-title":"Blood"},{"key":"bib38-20230924","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-13-1482","article-title":"Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies","volume":"19","year":"2013","journal-title":"Clin Cancer Res"},{"key":"bib39-20230924","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","year":"2014","journal-title":"Blood"},{"key":"bib40-20230924","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jmoldx.2015.01.007","article-title":"Accurate classification of germinal center B-cell\u2013like\/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: a CALYM study","volume":"17","year":"2015","journal-title":"J Mol Diagn"},{"key":"bib41-20230924","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","year":"2014","journal-title":"Blood"},{"key":"bib42-20230924","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","year":"2007","journal-title":"Blood"},{"key":"bib43-20230924","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"bib44-20230924","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","year":"2012","journal-title":"Blood"},{"key":"bib45-20230924","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","year":"2014","journal-title":"Nature genetics"},{"key":"bib46-20230924","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","year":"2014","journal-title":"Nature genetics"},{"key":"bib47-20230924","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas","volume":"128","year":"2016","journal-title":"Blood"},{"key":"bib48-20230924","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2017.186767","article-title":"RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells","volume":"103","year":"2018","journal-title":"Haematologica"},{"key":"bib49-20230924","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","year":"2017","journal-title":"Haematologica"},{"key":"bib50-20230924","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","year":"2014","journal-title":"Blood"},{"key":"bib51-20230924","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","year":"2017","journal-title":"Blood"},{"key":"bib52-20230924","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","year":"2015","journal-title":"Cancer Cell"},{"key":"bib53-20230924","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","article-title":"Genetic subtyping of breast implant\u2013associated anaplastic large cell lymphoma","volume":"132","year":"2018","journal-title":"Blood"},{"key":"bib54-20230924","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","article-title":"Dual JAK1 and STAT3 mutations in a breast implant\u2013associated anaplastic large cell lymphoma","volume":"473","year":"2018","journal-title":"Virchows Arch"},{"key":"bib55-20230924","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant\u2013associated ALCL","volume":"135","year":"2020","journal-title":"Blood"},{"key":"bib56-20230924","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant\u2013associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"bib57-20230924","first-page":"24","article-title":"Breast implant\u2013associated anaplastic large cell lymphoma and other rare T-cell lymphomas","volume":"37","year":"2019","journal-title":"Hematol Oncol"},{"key":"bib58-20230924","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","year":"2014","journal-title":"Blood"},{"key":"bib59-20230924","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","year":"2019","journal-title":"Blood"},{"key":"bib60-20230924","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus\u2013associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","year":"2018","journal-title":"Haematologica"},{"key":"bib61-20230924","first-page":"133","article-title":"On the pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis","volume":"10","year":"1902","journal-title":"Johns Hopkins Hosp Rep"},{"issue":"suppl 1","key":"bib62-20230924","first-page":"11","article-title":"Biology of Hodgkin's lymphoma","volume":"13","year":"2002","journal-title":"Ann Oncol"},{"key":"bib63-20230924","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib64-20230924","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","year":"1996","journal-title":"J Exp Med"},{"key":"bib65-20230924","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1073\/pnas.94.17.9337","article-title":"Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells","volume":"94","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib66-20230924","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199708143370703","article-title":"Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"bib67-20230924","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199708143370704","article-title":"Clonality in nodular lymphocyte-predominant Hodgkin's disease","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"bib68-20230924","first-page":"1123","article-title":"Classical Hodgkin's disease: clinical impact of the immunophenotype","volume":"151","year":"1997","journal-title":"Am J Pathol"},{"key":"bib69-20230924","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465","article-title":"Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease","volume":"87","year":"1996","journal-title":"Blood"},{"key":"bib70-20230924","first-page":"29","article-title":"Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell\u2013derived nodular type","volume":"138","year":"1991","journal-title":"Am J Pathol"},{"key":"bib71-20230924","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"bib72-20230924","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","article-title":"The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)","volume":"122","year":"2013","journal-title":"Blood"},{"key":"bib73-20230924","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte- predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease [see comments]","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"key":"bib74-20230924","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/modpathol.2009.54","article-title":"Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers","volume":"22","year":"2009","journal-title":"Mod Pathol"},{"issue":"suppl 5","key":"bib75-20230924","first-page":"S31","article-title":"Workshop report on Hodgkin's disease and related diseases (\u2018grey zone\u2019 lymphoma)","volume":"9","year":"1998","journal-title":"Ann Oncol"},{"key":"bib76-20230924","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"bib77-20230924","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","year":"2014","journal-title":"Blood"},{"key":"bib78-20230924","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","year":"2011","journal-title":"Haematologica"},{"key":"bib79-20230924","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","year":"2011","journal-title":"Mod Pathol"},{"key":"bib80-20230924","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3324\/haematol.2016.152256","article-title":"Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association","volume":"102","year":"2017","journal-title":"Haematologica"},{"key":"bib81-20230924","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","year":"2017","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"bib82-20230924","first-page":"S57","article-title":"Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications","volume":"26","year":"2013","journal-title":"Mod Pathol"},{"key":"bib83-20230924","doi-asserted-by":"crossref","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","article-title":"Nodular lymphocyte predominant hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma\u2014endpoints of a spectrum of one disease?","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"bib84-20230924","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/leu.2015.328","article-title":"Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma","volume":"30","year":"2016","journal-title":"Leukemia"},{"key":"bib85-20230924","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1155\/2012\/480160","article-title":"Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population","volume":"26","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"bib86-20230924","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/j.1572-0241.2008.01794.x","article-title":"Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study","volume":"103","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"bib87-20230924","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","year":"2016","journal-title":"Nat Commun"},{"key":"bib88-20230924","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","year":"2017","journal-title":"J Exp Med"},{"key":"bib89-20230924","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","year":"2013","journal-title":"Blood"},{"key":"bib90-20230924","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","article-title":"Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update","volume":"35","year":"2017","journal-title":"Hematol Oncol"},{"key":"bib91-20230924","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","article-title":"Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract","volume":"131","year":"2018","journal-title":"Blood"},{"key":"bib92-20230924","first-page":"haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","year":"2019","journal-title":"Haematologica"},{"key":"bib94-20230924","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","year":"2005","journal-title":"Blood"},{"key":"bib95-20230924","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","year":"2019","journal-title":"Blood"},{"key":"bib97-20230924","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","year":"2008","journal-title":"Blood"},{"key":"bib98-20230924","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"bib99-20230924","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semdp.2016.11.007","article-title":"Cutaneous marginal zone lymphomas","volume":"34","year":"2017","journal-title":"Semin Diagn Pathol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:26:28Z","timestamp":1695533188000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000451","relation":{},"ISSN":["1540-336X","1528-9117"],"issn-type":[{"value":"1540-336X","type":"electronic"},{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}